Loading…
Flow cytometry: An improved method for the selection of highly productive gene-amplified CHO cells using flow cytometry
In previous work, we clarified the relationship between the productivity and stability of gene‐amplified cells and the location of the amplified gene. The location of the amplified gene enabled us to classify resistant cells into two types. One type of resistant cell group, in which the amplified ge...
Saved in:
Published in: | Biotechnology and bioengineering 2001-09, Vol.74 (5), p.435-442 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In previous work, we clarified the relationship between the productivity and stability of gene‐amplified cells and the location of the amplified gene. The location of the amplified gene enabled us to classify resistant cells into two types. One type of resistant cell group, in which the amplified genes were observed near the telomeric region, was named the “telomere type.” The other type of cell group, in which the amplified genes were observed in other chromosomal regions, was named the “other type.” The phenotypes of these two types of cells are very different. In this experiment, using a fluorescein isothiocyanate‐labeled methotrexate (F‐MTX) reagent with flow cytometry, we were easily able to distinguish between highly productive cells and the other types of cells. The level of fluorescence differed according to the difference in resistance to MTX. Based on this new finding, highly productive gene‐amplified cells could be isolated from heterogeneous gene‐amplified cell pools more easily than by the method of limiting‐dilution assay. The limiting‐dilution method requires several months to obtain highly productive gene‐amplified cells, while our flow‐cytometry‐based method of selection requires only a few weeks. © 2001 John Wiley & Sons, Inc. Biotechnol Bioeng 74: 435–442, 2001. |
---|---|
ISSN: | 0006-3592 1097-0290 |
DOI: | 10.1002/bit.1134 |